Lazard Asset Management LLC Castle Biosciences Inc Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$18.08 - $30.0 $34,532 - $57,300
-1,910 Reduced 46.67%
2,183 $51,000
Q3 2022

Nov 14, 2022
BUY
$22.51 - $34.32 $18,480 - $28,176
821 Added 25.09%
4,093 $106,000
Q2 2022

Aug 09, 2022
BUY
$16.0 - $45.99 $31,920 - $91,750
1,995 Added 156.23%
3,272 $71,000
Q1 2022

May 13, 2022
BUY
$33.17 - $46.98 $42,358 - $59,993
1,277 New
1,277 $57,000

Others Institutions Holding CSTL

# of Institutions
199
Shares Held
25.9M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $743M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email